Abstract
Bronchopulmonary Dysplasia (BPD) continues to be a major problem despite advances in the management of the sick preterm. Current evidence supports a multifactorial etiology to this disease. Prematurity is the cardinal factor; others include pulmonary baro/volu trauma, hyperoxia, and inflammation. A clearer understanding of genetic susceptibility for BPD has recently emerged. Twin studies have shown that 53% of the variance for BPD is genetic. This article will attempt to review the published literature appraising the relationship between single nucleotide polymorphisms of putative causal genes and susceptibility to BPD. These studies, though small in size, spark interest in further genetic association studies to identify candidate genes that contribute to the diverse pathophysiology of BPD.
Keywords: Lung, single nucleotide polymorphisms, cytokines, preterm newborn
Current Respiratory Medicine Reviews
Title: Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?
Volume: 2 Issue: 3
Author(s): Anupama Shetty, Jeffrey R. Gruen and Vineet Bhandari
Affiliation:
Keywords: Lung, single nucleotide polymorphisms, cytokines, preterm newborn
Abstract: Bronchopulmonary Dysplasia (BPD) continues to be a major problem despite advances in the management of the sick preterm. Current evidence supports a multifactorial etiology to this disease. Prematurity is the cardinal factor; others include pulmonary baro/volu trauma, hyperoxia, and inflammation. A clearer understanding of genetic susceptibility for BPD has recently emerged. Twin studies have shown that 53% of the variance for BPD is genetic. This article will attempt to review the published literature appraising the relationship between single nucleotide polymorphisms of putative causal genes and susceptibility to BPD. These studies, though small in size, spark interest in further genetic association studies to identify candidate genes that contribute to the diverse pathophysiology of BPD.
Export Options
About this article
Cite this article as:
Shetty Anupama, Gruen R. Jeffrey and Bhandari Vineet, Is There a Genetic Susceptibility to Bronchopulmonary Dysplasia?, Current Respiratory Medicine Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339806778018935
DOI https://dx.doi.org/10.2174/157339806778018935 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of QSAR studies to Discover New Drug-like Compounds Actives Against Leishmaniasis and Trypanosomiasis
Current Topics in Medicinal Chemistry Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Current Pharmaceutical Design In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead
Current Molecular Imaging (Discontinued) Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans
Letters in Drug Design & Discovery Entrainment of the Human Circadian Clock to the Light-Dark Cycle and its Impact on Patients in the ICU and Nursing Home Settings
Current Pharmaceutical Design A Validation and Estimation of Total Eicosapentaenoic and Docosahexaenoic acids Using LC-MS/MS with Rapid Hydrolysis Enzymatic Method for Hydrolysis of Omega Lipids in Human Plasma and its Application in the Pharmacokinetic Study
Current Pharmaceutical Analysis A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery Inflammatory Cytokines, Growth Factors, and Depression
Current Pharmaceutical Design What We Learnt from Randomized Clinical Trials and Cohort Studies of Antioxidant Vitamin? : Focus on Vitamin E and Cardiovascular Disease
Current Pharmaceutical Biotechnology The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model
CNS & Neurological Disorders - Drug Targets New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination?
Recent Patents on Cardiovascular Drug Discovery The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology Mediterranean Diet And Longevity: An Example Of Nutraceuticals?
Current Vascular Pharmacology Mechanisms of Medial Arterial Calcification in Diabetes
Current Pharmaceutical Design Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets Neurodevelopmental Delay and Intellectual Disability in Pediatric Heart Transplant
Current Psychiatry Reviews Hyperhomocysteinemia in Movement Disorders: Current Evidence and Hypotheses
Current Vascular Pharmacology Anthracycline-Induced Cardiotoxicity
Cardiovascular & Hematological Agents in Medicinal Chemistry Metabolic Effects of Bile Acids in the Gut in Health and Disease
Current Medicinal Chemistry Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design